Nasdaq stocks posting largest percentage decreases
moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]
TKMR
2:46 am Tekmira Pharma presents recent advances in mRNA delivery at Scientific Symposium
moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]
Tekmira Presents Recent Advances in mRNA Delivery at Scientific Symposium
[GlobeNewswire] – VANCOUVER, British Columbia — Tekmira Pharmaceuticals Corporation , a leading developer of RNA therapeutics, announced that recent advances in the enablement of messenger RNA (mRNA) using Tekmira’s lipid … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]
Tekmira price target raised to $31 from $17 at Maxim
moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]
Tekmira Announces Filing of Shelf Prospectus and Registration Statement
[GlobeNewswire] – VANCOUVER, British Columbia — Tekmira Pharmaceuticals Corporation , a developer of RNA interference (RNAi) therapeutics, today announced that it has filed a preliminary short form base shelf prospectus … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]
Webcast Advisory: Tekmira to Present at the 2014 RBC Capital Markets’ Global Healthcare Conference
[GlobeNewswire] – VANCOUVER, British Columbia — Tekmira Pharmaceuticals Corporation , a leading developer of RNA interference (RNAi) therapeutics, today announced that Dr. Mark Murray, President and CEO of Tekmira, will … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]
Tekmira Announces New Appointment to Board of Directors
[GlobeNewswire] – VANCOUVER, B.C. — Tekmira Pharmaceuticals Corporation , a leading developer of RNA interference (RNAi) therapeutics, today announced the appointment of Ms. Peggy Phillips to its Board of Directors. moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]
Early-Stage Clinical Data Highlights From AACR 2013
moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]
Tekmira’s TKM-PLK1 Is Promising For Solid Tumors
moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]
Tekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial at American Association for Cancer Research (AACR) Meeting
[at noodls] – TKM-PLK1 Resulted in Clinical Benefit in 44% of Evaluable Patients Receiving Doses in Effective Range Tekmira to Initiate a Phase II Clinical Trial in Gastrointestinal Carcinoid (Neuroendocrine) Cancer … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]
